The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility and clinical utility of cancer whole genome and transcriptome sequencing for pediatric and young adult solid tumors.
 
Neerav Shukla
Consulting or Advisory Role - Syndax
 
Max Levine
No Relationships to Disclose
 
Gunes Gundem
Consulting or Advisory Role - Isabl Technologies
 
Barbara Spitzer
No Relationships to Disclose
 
Jesus Gutierrez-Abril
No Relationships to Disclose
 
Nancy Bouvier
No Relationships to Disclose
 
Juan E. Arango Ossa
No Relationships to Disclose
 
Juan Medina-Martinez
No Relationships to Disclose
 
Emily Stockfisch
No Relationships to Disclose
 
Tara O'Donohue
Research Funding - Bayer (Inst); Turning Point Therapeutics (Inst)
 
Ahmet Zehir
Stock and Other Ownership Interests - Arcus Biosciences; Mirati Therapeutics
Honoraria - Illumina
 
Agnes Viale
No Relationships to Disclose
 
Shakeel Modak
Consulting or Advisory Role - Illumina; Ymabs Therapeutics Inc
Patents, Royalties, Other Intellectual Property - Two patents pending; no financial benefit
 
Filemon S. Dela Cruz
No Relationships to Disclose
 
Emily K Slotkin
Research Funding - Lilly (Inst); Lilly (Inst)
 
Matthias A. Karajannis
Stock and Other Ownership Interests - Johnson & Johnson (I)
Consulting or Advisory Role - AstraZeneca; Bayer; CereXis; QED Therapeutics; Recursion Pharmaceuticals
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer
(OPTIONAL) Uncompensated Relationships - Debiopharm Group (Inst)
 
Julia Lynne Glade Bender
Research Funding - Bayer (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent on a T lympboblastic lymphoma cell line, CUTLL1
Travel, Accommodations, Expenses - Amgen (Inst)
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Merck; SpringWorks Therapeutics
 
Michael Francis Walsh
No Relationships to Disclose
 
Andrew Kung
Stock and Other Ownership Interests - Imago Pharma; Isabl Technologies
Consulting or Advisory Role - DarwinHealth; Emendo; Imago Pharma; Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Licensing and royalty from bioluminescence imaging models
 
Elli Papaemmanuil
Leadership - Isabl Technologies; Isabl Technologies
Stock and Other Ownership Interests - Isabl Technologies
Honoraria - Celgene; Novartis
Speakers' Bureau - Illumina
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene; Novartis